Cargando…
MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo
Despite advances in diagnosis and treatment, the survival of non-small cell lung cancer (NSCLC) patients remains poor; therefore, improved understanding of the disease mechanism and novel treatment strategies are needed. Downregulation of SMAD4 and dysregulated expression of miR-205 have been report...
Autores principales: | Zeng, Yuanyuan, Zhu, Jianjie, Shen, Dan, Qin, Hualong, Lei, Zhe, Li, Wei, Liu, Zeyi, Huang, Jian-an |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458170/ https://www.ncbi.nlm.nih.gov/pubmed/28199217 http://dx.doi.org/10.18632/oncotarget.10339 |
Ejemplares similares
-
Repression of Smad4 by miR-205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines
por: Zeng, Yuanyuan, et al.
Publicado: (2021) -
Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer
por: Qin, Hualong, et al.
Publicado: (2016) -
CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer
por: Zhu, Jianjie, et al.
Publicado: (2017) -
Variant SNPs at the microRNA complementary site in the B7-H1 3′-untranslated region increase the risk of non-small cell lung cancer
por: Du, Wenwen, et al.
Publicado: (2017) -
MicroRNA‐4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non‐small cell lung cancer
por: Ling, Chunhua, et al.
Publicado: (2019)